← Leaderboards
Priya U. Kumthekar
Northwestern University At Chicago
$1,374,987
Attributed
$2,259,055
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $601.8K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,259,055 · 2
By mechanism
R01$1,768,137 · 1
P30$490,918 · 1
Top collaborators
- Amy Beth Heimberger3 shared
Most similar at Northwestern University At Chicago
Same institution · by research overlap
- Tanya Simuni Simuni$20,339,132
- Mark Agulnik$1,506,503
- Sanjiv J Shah$26,804,224
- Rintaro Hashizume$3,035,663
- Maya Srikanth Graham$882,803
Others in their field
Other Emerging Leaders on “Childhood”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,207,652
- Leonard Freedman · Leidos Biomedical Research, Inc.$73,356,290
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Gina Montealegre · Leidos Biomedical Research, Inc.$19,781,641
- Lynn Briscoe · Leidos Biomedical Research, Inc.$18,486,552
Research focus
ChildhoodMalignant NeoplasmsClinical TrialsDependenceDendritic CellsAnimal ModelDendritic Cell ActivationAdaptive ImmunityAntigen PresentationCombined Modality TherapyAntigen-Presenting CellsBrain Stem GliomaCancer CellAntitumor ResponseCd11c AntigensAnimalsCd3 AntigensCell PhysiologyCellsBlood - Brain Barrier AnatomyBrainCohortBrain NeoplasmsDose
Grant awards (4)
A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and Radiation$598,126
R01 · FY2025 · CA
A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and Radiation$568,219
R01 · FY2024 · CA
A Phase II Clinical Trial in Newly Diagnosed Glioblastoma Patients Treated with WP1066 and Radiation$601,792
R01 · FY2023 · CA
Clinical Protocol and Data Management$490,918
P30 · FY2021 · CA · contact PI